Travaux et publications
Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information? - Markopoulos C, van de Velde C, Zarca D, Ozmen V, Masetti R.
Use of guidelines and heterogeneity of decision making for adjuvant chemotherapy in hormone-receptor positive, HER2-negative, early breast cancer: results of a French national survey - Fekih M, Petit T, Zarca D, Guinebretière JM, André F, Pierga JY, Namer M, Gligorov J, Delaloge S.
Breast cancers and gene expression signatures: Here and now. - Zarca D.
Chemotherapy by the intravenous and intraperitoneal routes combined in ovarian cancer. - Zylberberg B, Ravina JH, Salat-Baroux J, Madelenat P, Zarca D, Dormont D.
Secondary cytoreductive surgery in ovarian cancer. - Michel G, Zarca D, Castaigne D, Prade M.
Michel G, Pfeiffer F, Duvillard P, Prade M, Castaigne D, Zarca D, Pejovic-Lenfant MH, Gerbaulet A, Lhomme C. - Sarcoma of the uterus. A clinical study apropos of 50 surgically treated cases at the Gustave Roussy Institute.
Bacterial infections (and pregnancy) - Zarca D, Proust A.
Patients experiences following breast cancer treatment: an exploratory survey of personal and work experiences of breast cancer patients from three European countries. - Braybrooke JP, Mimoun S, Zarca D, Elia D, Pinder B, Lloyd AJ, Breheny K, Lomazzi M, Borisch.
Parasitic infections and pregnancy. - Zarca D, Sedbon E.